Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’

Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’

U.S. President Donald Trump speaks next to Defense Secretary Pete Hegseth during a cabinet meeting at the White House in Washington, D.C., U.S., July 8, 2025. Kevin Lamarque | Reuters President Donald Trump on Tuesday threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. “very soon.”  “They’re going to be tariffs … Read more

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump’s plan

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump’s plan

The Johnson & Johnson logo displayed on a monitor. Sopa Images | Lightrocket | Getty Images Two Democratic lawmakers on Tuesday pressed five of the nation’s largest pharmaceutical companies about their low tax bills and whether they support extending massive tax cuts for the industry in the GOP reconciliation bill. Sen. Elizabeth Warren, D-Mass., and … Read more

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer

Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering Love Employee | Istock | Getty Images Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its … Read more

Trump signs order to boost domestic drug manufacturing as pharma tariffs loom

Trump signs order to boost domestic drug manufacturing as pharma tariffs loom

U.S. President Donald Trump speaks before signing executive orders in the Oval Office at the White House, in Washington, D.C., U.S., May 5, 2025. Leah Millis | Reuters President Donald Trump on Monday signed an executive order to incentivize prescription drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build new production … Read more

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave … Read more

Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise

Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise

Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per share of $1.80 beat expectations … Read more

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S.  Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% … Read more

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated … Read more

AbbVie is the newest potential weight loss drug player

AbbVie is the newest potential weight loss drug player

A sign stands outside an Abbvie facility in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The booming weight loss drug market has gained a new potential competitor.  AbbVie … Read more